Magnus Financial Group LLC Gilead Sciences, Inc. Transaction History

Magnus Financial Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $287,668 - $327,784	-5,078 Closed	0 $0
Q3 2020 Nov 05, 2020	SELL	$62.1 - $78.08 $346,393 - $435,530	-5,578 Reduced 52.35%	5,078 $321,000
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $16,638 - $19,320	230 Added 2.21%	10,656 $820,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $408,034 - $522,633	6,515 Added 166.58%	10,426 $779,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $1,294 - $1,423	21 Added 0.54%	3,911 $254,000
Q3 2019 Nov 08, 2019	BUY	$62.51 - $69.0 $2,062 - $2,277	33 Added 0.86%	3,890 $247,000
Q2 2019 Aug 05, 2019	BUY	$61.87 - $69.38 $238,632 - $267,598	3,857 New	3,857 $261,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Magnus Financial Group LLC, based on Form 13F filings with the SEC.

Stay updated on Magnus Financial Group LLC with notifications on news.